Comments on: Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting https://enterabio.com/news/entera-bio-to-present-new-clinical-data-from-phase-2-trial-of-eb613-at-the-2025-north-american-menopause-society-nams-annual-meeting/ Global Leader in Oral Delivery of Therapeutic Proteins Thu, 16 Oct 2025 20:05:33 +0000 hourly 1 https://wordpress.org/?v=6.8.1